Charles Brink

2.3k citations
53 papers · 1.9k · h-index 25

Impact in

    • Eicosanoids and Hypertension Pharmacology
  • Physiology top 2%
    • Asthma and respiratory diseases
    • Nitric Oxide and Endothelin Effects

Papers in

Charles Brink

52 papers receiving 1.9k citations

Peers

Charles Brink
Comparison fields: 5 of 100
  • Biochemistry 303
  • Physiology 827
  • Pharmacology 356
  • Immunology and Allergy 111
  • Immunology 383
Replace Xavier Norel with:
Xavier Norel France
Aksam Merched France
Shivendra D. Shukla United States
Kyungho Chang Japan
Armin Hatzelmann Germany
Hozuka Akita Japan
Yuchang Fu United States
E. Schleicher Germany
Leonard M. Hillegass United States
K.E. Eakins United States
Charles Brink relative to Xavier Norel France Xavier Norel's profile →
Citations per field
00.5×1.5×
Xavier Norel · 1×
Citations per year

Countries citing papers authored by Charles Brink

Since Specialization
Citations

This map shows the geographic impact of Charles Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Brink more than expected).

Fields of papers citing papers by Charles Brink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Brink. The network helps show where Charles Brink may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles Brink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Brink Line = papers co-authored together Charles Brink links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006378
2 2003228
3 1999108
4 198392
5 199976
6 198069
7 200168
8 198854
9 200451
10 201349
11 197748
12 200444
13 200043
14 200943
15 200042
16 199940
17 200038
18 200237
19 200436
20 198235

About Charles Brink

Charles Brink is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Pharmacology, Molecular Biology and Immunology, having authored 53 papers that have together received 1.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (30 papers), Inflammatory mediators and NSAID effects (12 papers), Nitric Oxide and Endothelin Effects (10 papers), Respiratory and Cough-Related Research (10 papers), Mast cells and histamine (7 papers), Pulmonary Hypertension Research and Treatments (6 papers), Allergic Rhinitis and Sensitization (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). The work is most often cited by research in Biochemistry (303 citations), Physiology (827 citations), Pharmacology (356 citations), Immunology and Allergy (111 citations) and Immunology (383 citations). Charles Brink has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Xavier Norel, Carlos Labat, Sven‐Erik Dahlén, Laurence Walch, Jean‐Pierre Gascard, Takao Shimizu, Douglas W.P. Hay, Charles N. Serhan, Jeffrey M. Drazen and Takehiko Yokomizo. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology, Advances in experimental medicine and biology, Pharmacological Reviews and International Archives of Allergy and Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact